Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.

Goldstein FC, Loring DW, Thomas T, Saleh S, Hajjar I.

J Alzheimers Dis. 2019 Oct 1. doi: 10.3233/JAD-190468. [Epub ahead of print]

PMID:
31594225
2.

Rationale and Design of the Emory Healthy Aging and Emory Healthy Brain Studies.

Goetz ME, Hanfelt JJ, John SE, Bergquist SH, Loring DW, Quyyumi A, Clifford GD, Vaccarino V, Goldstein F, Johnson Nd TM, Kuerston R, Marcus M, Levey AI, Lah JJ.

Neuroepidemiology. 2019 Aug 27:1-14. doi: 10.1159/000501856. [Epub ahead of print]

PMID:
31454799
3.

Subjective Memory Complaints in White and African American Participants.

John SE, Evans SA, Hanfelt J, Loring DW, Goldstein FC.

J Geriatr Psychiatry Neurol. 2019 Aug 13:891988719868305. doi: 10.1177/0891988719868305. [Epub ahead of print]

PMID:
31409180
4.

If Invalid PVT Scores Are Obtained, Can Valid Neuropsychological Profiles Be Believed?

Loring DW, Goldstein FC.

Arch Clin Neuropsychol. 2019 Jul 29. pii: acz028. doi: 10.1093/arclin/acz028. [Epub ahead of print]

PMID:
31365058
5.

Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder.

Ozturk T, Kollhoff A, Anderson AM, Christina Howell J, Loring DW, Waldrop-Valverde D, Franklin D, Letendre S, Tyor WR, Hu WT.

Sci Rep. 2019 Jun 19;9(1):8733. doi: 10.1038/s41598-019-45418-2.

6.

Comparative neuropsychological effects of carbamazepine and eslicarbazepine acetate.

Meador KJ, Seliger J, Boyd A, Razavi B, Falco-Walter J, Le S, Loring DW.

Epilepsy Behav. 2019 May;94:151-157. doi: 10.1016/j.yebeh.2019.02.034. Epub 2019 Mar 30.

PMID:
30939410
7.

General Educational Development (GED) and Educational Attainment Equivalency for Demographically Adjusted Norms.

Hewitt KC, Cody MW, Marker CD, Loring DW.

Arch Clin Neuropsychol. 2019 Feb 1. doi: 10.1093/arclin/acz003. [Epub ahead of print]

PMID:
30715094
8.

Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study.

Cohen MJ, Meador KJ, May R, Loblein H, Conrad T, Baker GA, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Epilepsy Behav. 2019 Mar;92:154-164. doi: 10.1016/j.yebeh.2018.12.031. Epub 2019 Jan 17.

PMID:
30660966
9.

Incremental Validity of Montreal Cognitive Assessment Index Scores in Mild Cognitive Impairment and Alzheimer Disease.

Goldstein FC, Milloy A, Loring DW; for the Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2018;45(1-2):49-55. doi: 10.1159/000487131. Epub 2018 Apr 11.

10.

NIH Toolbox Picture Sequence Memory Test for Assessing Clinical Memory Function: Diagnostic Relationship to the Rey Auditory Verbal Learning Test.

Loring DW, Bowden SC, Staikova E, Bishop JA, Drane DL, Goldstein FC.

Arch Clin Neuropsychol. 2019 Mar 1;34(2):268-276. doi: 10.1093/arclin/acy028.

PMID:
29608637
11.

Paradigm Shifts in the Neuropsychology of Epilepsy.

Hermann B, Loring DW, Wilson S.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):791-805. doi: 10.1017/S1355617717000650. Review.

12.

Methylphenidate, cognition, and epilepsy: A 1-month open-label trial.

Adams J, Alipio-Jocson V, Inoyama K, Bartlett V, Sandhu S, Oso J, Barry JJ, Loring DW, Meador KJ.

Epilepsia. 2017 Dec;58(12):2124-2132. doi: 10.1111/epi.13917. Epub 2017 Oct 9.

13.

Relationship of Reaction Time to Perception of a Stimulus and Volitionally Delayed Response.

Meador KJ, Boyd A, Loring DW.

Cogn Behav Neurol. 2017 Jun;30(2):57-61. doi: 10.1097/WNN.0000000000000121.

PMID:
28632522
14.

Consciousness post corpus callosotomy.

Meador KJ, Loring DW, Sathian K.

Brain. 2017 Jul 1;140(7):e38. doi: 10.1093/brain/awx106. No abstract available.

PMID:
28460007
15.

Methylphenidate, cognition, and epilepsy: A double-blind, placebo-controlled, single-dose study.

Adams J, Alipio-Jocson V, Inoyama K, Bartlett V, Sandhu S, Oso J, Barry JJ, Loring DW, Meador K.

Neurology. 2017 Jan 31;88(5):470-476. doi: 10.1212/WNL.0000000000003564. Epub 2016 Dec 28.

16.

Neuroimaging somatosensory perception and masking.

Meador KJ, Revill KP, Epstein CM, Sathian K, Loring DW, Rorden C.

Neuropsychologia. 2017 Jan 8;94:44-51. doi: 10.1016/j.neuropsychologia.2016.11.017. Epub 2016 Nov 26.

PMID:
27894900
17.

Randomized double-blind comparison of cognitive and EEG effects of lacosamide and carbamazepine.

Meador KJ, Loring DW, Boyd A, Echauz J, LaRoche S, Velez-Ruiz N, Korb P, Byrnes W, Dilley D, Borghs S, De Backer M, Story T, Dedeken P, Webster E.

Epilepsy Behav. 2016 Sep;62:267-75. doi: 10.1016/j.yebeh.2016.07.007. Epub 2016 Aug 10.

PMID:
27517350
18.

Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.

Anderson AM, Lennox JL, Mulligan MM, Loring DW, Zetterberg H, Blennow K, Kessing C, Koneru R, Easley K, Tyor WR.

J Neurovirol. 2017 Feb;23(1):106-112. doi: 10.1007/s13365-016-0466-z. Epub 2016 Jul 11.

19.

Editorial.

Bowden SC, Loring DW.

Neuropsychol Rev. 2016 Jun;26(2):107-8. doi: 10.1007/s11065-016-9322-4. No abstract available.

PMID:
27315064
20.

Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.

Anderson AM, Lennox JL, Nguyen ML, Waldrop-Valverde D, Tyor WR, Loring DW.

J Neurovirol. 2016 Dec;22(6):816-822. Epub 2016 May 31.

21.

Baseline somatization influences sport-related concussion recovery.

Loring DW, Makdissi M.

Neurology. 2016 May 17;86(20):1852-3. doi: 10.1212/WNL.0000000000002685. Epub 2016 Apr 20. No abstract available.

PMID:
27164669
22.

False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease.

Loring DW, Goldstein FC, Chen C, Drane DL, Lah JJ, Zhao L, Larrabee GJ; Alzheimer's Disease Neuroimaging Initiative.

Arch Clin Neuropsychol. 2016 Jun;31(4):313-31. doi: 10.1093/arclin/acw014. Epub 2016 Apr 15.

23.

Interictal epileptiform discharge effects on neuropsychological assessment and epilepsy surgical planning.

Drane DL, Ojemann JG, Kim MS, Gross RE, Miller JW, Faught RE Jr, Loring DW.

Epilepsy Behav. 2016 Mar;56:131-8. doi: 10.1016/j.yebeh.2016.01.001. Epub 2016 Feb 12. Review.

24.

Editorial.

Loring DW, Bowden SC.

Neuropsychol Rev. 2016 Mar;26(1):1-2. doi: 10.1007/s11065-015-9314-9. No abstract available.

PMID:
26809716
25.

A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures.

Drane DL, LaRoche SM, Ganesh GA, Teagarden D, Loring DW.

Epilepsy Behav. 2016 Jan;54:34-9. doi: 10.1016/j.yebeh.2015.10.026. Epub 2015 Nov 28.

26.

Developmental effects of antiepileptic drugs and the need for improved regulations.

Meador KJ, Loring DW.

Neurology. 2016 Jan 19;86(3):297-306. doi: 10.1212/WNL.0000000000002119. Epub 2015 Oct 30. Review.

27.

Differential neuropsychological outcomes following targeted responsive neurostimulation for partial-onset epilepsy.

Loring DW, Kapur R, Meador KJ, Morrell MJ.

Epilepsia. 2015 Nov;56(11):1836-44. doi: 10.1111/epi.13191. Epub 2015 Sep 19.

28.

The other side of epilepsy.

Tuchman R, Loring DW.

Epilepsia. 2015 Oct;56(10):1490-1. doi: 10.1111/epi.13104. Epub 2015 Aug 21. No abstract available.

29.

In response: Naming and recognition after laser amygdalohippocampotomy: Is the hippocampus involved?

Drane DL, Loring DW, Voets NL, Price M, Ojemann JG, Willie JT, Saindane AM, Phatak V, Ivanisevic M, Millis S, Helmers SL, Miller JW, Meador KJ, Gross RE.

Epilepsia. 2015 Aug;56(8):1318-9. doi: 10.1111/epi.13065. No abstract available.

30.

Quality of life and mood in patients with medically intractable epilepsy treated with targeted responsive neurostimulation.

Meador KJ, Kapur R, Loring DW, Kanner AM, Morrell MJ; RNS® System Pivotal Trial Investigators.

Epilepsy Behav. 2015 Apr;45:242-7. doi: 10.1016/j.yebeh.2015.01.012. Epub 2015 Mar 26.

31.

Cognitive impairment and evaluation in psychogenic nonepileptic seizures: an integrated cognitive-emotional approach.

Willment K, Hill M, Baslet G, Loring DW.

Clin EEG Neurosci. 2015 Jan;46(1):42-53. doi: 10.1177/1550059414566881. Review.

PMID:
25780266
32.

IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.

Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, García-Fiñana M, Gummery A, Kneen R, Loring DW, Mawer G, Meador KJ, Shallcross R, Clayton-Smith J; Liverpool and Manchester Neurodevelopment Group.

Neurology. 2015 Jan 27;84(4):382-90. doi: 10.1212/WNL.0000000000001182. Epub 2014 Dec 24.

33.

Better object recognition and naming outcome with MRI-guided stereotactic laser amygdalohippocampotomy for temporal lobe epilepsy.

Drane DL, Loring DW, Voets NL, Price M, Ojemann JG, Willie JT, Saindane AM, Phatak V, Ivanisevic M, Millis S, Helmers SL, Miller JW, Meador KJ, Gross RE.

Epilepsia. 2015 Jan;56(1):101-13. doi: 10.1111/epi.12860. Epub 2014 Dec 8.

34.

Quantification of Interictal Neuromagnetic Activity in Absence Epilepsy with Accumulated Source Imaging.

Xiang J, Tenney JR, Korman AM, Leiken K, Rose DF, Harris E, Yuan W, Horn PS, Holland K, Loring DW, Glauser TA.

Brain Topogr. 2015 Nov;28(6):904-14. doi: 10.1007/s10548-014-0411-5. Epub 2014 Oct 31.

PMID:
25359158
35.

First-degree relative risk: in utero levetiracetam and valproate exposure.

Loring DW.

Epilepsy Curr. 2014 Jul;14(4):186-8. doi: 10.5698/1535-7597-14.4.186. No abstract available.

36.

Low vitamin D levels are common in patients with epilepsy.

Teagarden DL, Meador KJ, Loring DW.

Epilepsy Res. 2014 Oct;108(8):1352-6. doi: 10.1016/j.eplepsyres.2014.06.008. Epub 2014 Jul 6.

37.

Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) Study Group.

JAMA Pediatr. 2014 Aug;168(8):729-36. doi: 10.1001/jamapediatrics.2014.118.

38.

Paying attention to school achievement in childhood absence epilepsy.

Loring DW.

Epilepsy Curr. 2014 Mar;14(2):68-70. doi: 10.5698/1535-7597-14.2.68. No abstract available.

39.

Cortical cartography reveals political and physical maps.

Loring DW, Gaillard WD, Bookheimer SY, Meador KJ, Ojemann JG.

Epilepsia. 2014 May;55(5):633-7. doi: 10.1111/epi.12553. Epub 2014 May 9.

40.

Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.

Cohen MJ, Meador KJ, Browning N, May R, Baker GA, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD study group.

Epilepsy Behav. 2013 Nov;29(2):308-15. doi: 10.1016/j.yebeh.2013.08.001. Epub 2013 Sep 5.

41.

Prenatal valproate exposure is associated with autism spectrum disorder and childhood autism.

Meador KJ, Loring DW.

J Pediatr. 2013 Sep;163(3):924. doi: 10.1016/j.jpeds.2013.06.050. No abstract available.

42.

Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.

Reisinger TL, Newman M, Loring DW, Pennell PB, Meador KJ.

Epilepsy Behav. 2013 Oct;29(1):13-8. doi: 10.1016/j.yebeh.2013.06.026. Epub 2013 Aug 2.

43.

Risks of in utero exposure to valproate.

Meador KJ, Loring DW.

JAMA. 2013 Apr 24;309(16):1730-1. doi: 10.1001/jama.2013.4001. No abstract available.

44.

Evaluating research for clinical significance: using critically appraised topics to enhance evidence-based neuropsychology.

Bowden SC, Harrison EJ, Loring DW.

Clin Neuropsychol. 2014;28(4):653-68. doi: 10.1080/13854046.2013.776636. Epub 2013 Mar 7.

PMID:
23463942
45.

The STROBE statement and neuropsychology: lighting the way toward evidence-based practice.

Loring DW, Bowden SC.

Clin Neuropsychol. 2014;28(4):556-74. doi: 10.1080/13854046.2012.762552. Epub 2013 Jan 29.

PMID:
23356727
46.

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW; NEAD Study Group.

Lancet Neurol. 2013 Mar;12(3):244-52. doi: 10.1016/S1474-4422(12)70323-X. Epub 2013 Jan 23.

47.

Acute lorazepam effects on neurocognitive performance.

Loring DW, Marino SE, Parfitt D, Finney GR, Meador KJ.

Epilepsy Behav. 2012 Nov;25(3):329-33. doi: 10.1016/j.yebeh.2012.08.019. Epub 2012 Oct 24.

PMID:
23103305
48.

Famous face identification in temporal lobe epilepsy: support for a multimodal integration model of semantic memory.

Drane DL, Ojemann JG, Phatak V, Loring DW, Gross RE, Hebb AO, Silbergeld DL, Miller JW, Voets NL, Saindane AM, Barsalou L, Meador KJ, Ojemann GA, Tranel D.

Cortex. 2013 Jun;49(6):1648-67. doi: 10.1016/j.cortex.2012.08.009. Epub 2012 Sep 5.

49.

Epilepsy: maximizing cognitive outcomes in epilepsy.

Loring DW, Meador KJ.

Nat Rev Neurol. 2012 Aug;8(8):416-7. doi: 10.1038/nrneurol.2012.143. Epub 2012 Jul 10. No abstract available.

PMID:
22777245
50.

Differential effects of antiepileptic drugs on neonatal outcomes.

Pennell PB, Klein AM, Browning N, Baker GA, Clayton-Smith J, Kalayjian LA, Liporace JD, Privitera M, Crawford T, Loring DW, Meador KJ; NEAD Study Group.

Epilepsy Behav. 2012 Aug;24(4):449-56. Epub 2012 Jun 29.

Supplemental Content

Loading ...
Support Center